NCT04991805 2025-04-25
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
AstraZeneca
Completed
Clinical Trials
39 trialsNCT00282516 2025-02-10
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
Phase NA Completed
NCT06061172 2024-12-12
gp-multitool
Universitätsklinikum Hamburg-Eppendorf
Phase NA Completed
NCT06457269 2024-11-27
EPLLMMRDC
North Sichuan Medical College
Phase NA Completed
NCT06459895 2024-06-14
Biochemical Role of Long Non-coding RNA MALAT 1 and Serum Tumor Necrosis Factor Alpha in Bronchial Asthma Patients.
Sohag University
Completed
NCT04574050 2024-03-19
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
Phase NA Completed
NCT02232126 2023-11-09
SWIFT
University of Southern California
Phase NA Completed
NCT03916237 2023-10-19
CREST
MetroHealth Medical Center
Phase NA Completed
NCT01760915 2023-08-02
University of Wisconsin Severe Asthma Research Program III
University of Wisconsin, Madison
Completed
NCT04939558 2023-06-02
CARES
TidalSense
Completed
NCT05226416 2023-05-09
ACTIV4
Eurasian Association of Therapists
Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT02517099 2023-03-06
PrIGMa
Imperial College London
Phase 2 Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT00366509 2021-08-02
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
National Institutes of Health Clinical Center (CC)
Completed
NCT02808689 2021-04-01
FAst
The Cleveland Clinic
Phase NA Completed
NCT02773095 2020-04-29
Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative
Boston University
Phase NA Completed
NCT03406325 2020-04-09
Mast Cell Activation Test in Allergic Disease
Hong Kong Sanatorium & Hospital
Completed
NCT03262428 2019-08-30
CoSMaS-ql
Hospices Civils de Lyon
Completed
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT01898767 2019-03-28
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses
University of Wisconsin, Madison
Completed
NCT02844842 2019-01-25
APOLO
Roxall Medicina España S.A
Completed
NCT02022761 2018-05-30
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
Phase 1 Completed
NCT00455923 2018-02-05
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
Phase 4 Completed
NCT03330301 2017-11-06
D-tect
Bispebjerg Hospital
Completed
NCT02440906 2017-10-03
WIN
University of Florida
Phase NA Completed
NCT00001893 2017-07-02
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02105012 2017-06-06
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
Phase 2 Completed
NCT00461500 2017-03-03
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Phase 4 Completed
NCT01089322 2017-02-16
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Phase 4 Completed
NCT00504361 2016-05-02
Q-BC
Weill Medical College of Cornell University
Completed
NCT00362739 2016-04-29
Blood Collection From Individuals With Lung Disease for Genetic Studies
Weill Medical College of Cornell University
Completed
NCT00621946 2014-02-04
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
Phase 4 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00785733 2010-12-02
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
AstraZeneca
Completed
NCT01161303 2010-07-13
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
University Hospital Southampton NHS Foundation Trust
Completed
NCT00141791 2009-08-07
Study Evaluating Etanercept in Moderate to Severe Asthma
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 2 Completed
NCT00850265 2009-03-27
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena
Phase NA Completed
NCT00276029 2006-05-04
TNF Alpha in Refractory Asthma
University Hospitals, Leicester
Phase NA Completed